163 related articles for article (PubMed ID: 24091520)
1. Case series: does a combination of anti-tnf antibodies and transient ileal fecal stream diversion in severe Crohn's colitis with perianal fistula prevent definitive stoma?
Uzzan M; Stefanescu C; Maggiori L; Panis Y; Bouhnik Y; Treton X
Am J Gastroenterol; 2013 Oct; 108(10):1666-8. PubMed ID: 24091520
[No Abstract] [Full Text] [Related]
2. Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn's disease: a pilot study.
Tonelli F; Giudici F; Asteria CR
Dis Colon Rectum; 2012 Aug; 55(8):870-5. PubMed ID: 22810472
[TBL] [Abstract][Full Text] [Related]
3. Genital fistulas in female Crohn's disease patients.: clinical characteristics and response to therapy.
de la Poza G; López-Sanroman A; Taxonera C; Marín-Jimenez I; Gisbert JP; Bermejo F; Opio V; Muriel A
J Crohns Colitis; 2012 Apr; 6(3):276-80. PubMed ID: 22405162
[TBL] [Abstract][Full Text] [Related]
4. Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report.
van der Hagen SJ; Baeten CG; Soeters PB; Russel MG; Beets-Tan RG; van Gemert WG
Dis Colon Rectum; 2005 Apr; 48(4):758-67. PubMed ID: 15750797
[TBL] [Abstract][Full Text] [Related]
5. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
Hyder SA; Travis SP; Jewell DP; McC Mortensen NJ; George BD
Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753
[TBL] [Abstract][Full Text] [Related]
6. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
[TBL] [Abstract][Full Text] [Related]
7. Prospective assessment of the effect on quality of life of anti-tumour necrosis factor therapy for perineal Crohn's fistulas.
Ng SC; Plamondon S; Gupta A; Burling D; Kamm MA
Aliment Pharmacol Ther; 2009 Oct; 30(7):757-66. PubMed ID: 19575762
[TBL] [Abstract][Full Text] [Related]
8. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
de Rossi TM; Krauss N; Voll RE; Nägel A; Weidenhiller M; Konturek PC; Hahn EG; Raithel M
Digestion; 2008; 78(4):195-200. PubMed ID: 19122456
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of tumor necrosis factor-alpha inhibitors in fistulising perianal Crohn's disease].
Bor R; Farkas K; Bálint A; Szűcs M; Abrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T
Orv Hetil; 2013 Dec; 154(49):1943-8. PubMed ID: 24292112
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of anti-TNF alpha antibodies in treatment of fistulizing Crohn's disease].
Rozpondek P; Zwolińska-Wcisło M; Przybylska M; Mach T
Przegl Lek; 2011; 68(9):602-5. PubMed ID: 22335009
[TBL] [Abstract][Full Text] [Related]
11. Autologous fibroblasts transplant after infliximab administration: a new approach in Crohn's perianal fistulas? Brief clinical report.
Ascanelli S; de Tullio D; Gregorio C; Azzena G; Occhionorelli S
Int J Colorectal Dis; 2007 Sep; 22(9):1135-6. PubMed ID: 16733649
[No Abstract] [Full Text] [Related]
12. Combined modality treatment for complex fistulating perianal Crohn's disease.
Antakia R; Shorthouse AJ; Robinson K; Lobo AJ
Colorectal Dis; 2013 Feb; 15(2):210-6. PubMed ID: 22672653
[TBL] [Abstract][Full Text] [Related]
13. Review article: medical, surgical and radiological management of perianal Crohn's fistulas.
Tozer PJ; Burling D; Gupta A; Phillips RK; Hart AL
Aliment Pharmacol Ther; 2011 Jan; 33(1):5-22. PubMed ID: 21083581
[TBL] [Abstract][Full Text] [Related]
14. Rapid recovery of a rectovaginal fistula with infliximab in a patient with Crohn's disease.
Hagiu C; Badea R; Serban A; Petrar S; Andreica V
J Gastrointestin Liver Dis; 2010 Sep; 19(3):329-32. PubMed ID: 20922201
[TBL] [Abstract][Full Text] [Related]
15. Loop ileostomy for anorectal Crohn's disease.
Grant DR; Cohen Z; McLeod RS
Can J Surg; 1986 Jan; 29(1):32-5. PubMed ID: 3940583
[TBL] [Abstract][Full Text] [Related]
16. [Adalimumab in infliximab refractory Crohn's disease -- the next generation of anti-TNF-alpha-therapy?].
Heidemann J; Kucharzik T
Z Gastroenterol; 2005 Jul; 43(7):689-90. PubMed ID: 16001352
[No Abstract] [Full Text] [Related]
17. CD4+CD161+ T lymphocytes infiltrate Crohn's disease-associated perianal fistulas and are reduced by anti-TNF-α local therapy.
Maggi L; Capone M; Giudici F; Santarlasci V; Querci V; Liotta F; Ficari F; Maggi E; Tonelli F; Annunziato F; Cosmi L
Int Arch Allergy Immunol; 2013; 161(1):81-6. PubMed ID: 23257766
[TBL] [Abstract][Full Text] [Related]
18. Fistulizing Crohn's disease.
Felley C; Mottet C; Juillerat P; Pittet V; Froehlich F; Vader JP; Michetti P; Gonvers JJ
Digestion; 2007; 76(2):109-12. PubMed ID: 18239401
[TBL] [Abstract][Full Text] [Related]
19. Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imaging.
Karmiris K; Bielen D; Vanbeckevoort D; Vermeire S; Coremans G; Rutgeerts P; Van Assche G
Clin Gastroenterol Hepatol; 2011 Feb; 9(2):130-6. PubMed ID: 21056696
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients.
Mohabbat AB; Sandborn WJ; Loftus EV; Wiesner RH; Bruining DH
Aliment Pharmacol Ther; 2012 Sep; 36(6):569-74. PubMed ID: 22779779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
